TIGER-CTL019 phase II trial of Tisagenlecleucel in elderly patients with first-relapsed or primary refractory aggressive B-cell Non-Hodgkin Lymphoma
ONCOLOGY RESEARCH AND TREATMENT(2021)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ONCOLOGY RESEARCH AND TREATMENT(2021)